Novaris’ Kisqali Cuts Breast Cancer Recurrence Shows Lasting Benefits – ESMO
Novartis' Kisqali in a new analysis showed a 28.5% reduction in the risk of breast cancer recurrence in patients with early breast cancer.…
All business news as they happen.
Novartis' Kisqali in a new analysis showed a 28.5% reduction in the risk of breast cancer recurrence in patients with early breast cancer.…
FUSO is displaying the all-electric eCanter with various body types and safety features at the IAA Transportation event.
Daimler Truck's focus on CO2-neutral long-distance haulage, with series production of Mercedes-Benz eActros 600 starting in November.
Imfinzi, in combination with chemotherapy, reduces recurrence risk by 32% and death risk by 25% compared to chemotherapy alone for muscle-invasive bladder cancer…
Merck & Co. announced that KEYTRUDA® with Trastuzumab and Chemotherapy improves survival in HER2-positive gastric cancer patients compared to Trastuzumab and Chemotherapy alone.…
JPMorgan Chase declares dividends on Series CC preferred stock
AstraZeneca's Enhertu displayed significant effectiveness in patients with HER2-positive metastatic breast cancer and brain metastases, achieving a 61.6% progression-free survival rate at one…
JD Sports Fashion announced a new directorate appointment on their website.
Heidelberg Materials Secures Majority Stake in Asment de Témara and Complete Ownership of Grabemaro
Chevron Shipping Company and MOL are installing Wind Challenger on an LNG carrier.